Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 90 of 164 results for atrial fibrillation

  1. Diagnostics Assessment Programme

    VERO and NObreath April 2014 DG12 Review decision DG14 Atrial fibrillation and heart valve disease: self-monitoring coagulation status...

  2. Further research is recommended to assess the diagnostic yield of the BioMonitor 2‑AF and Confirm Rx (or later devices) for atrial fibrillation when used in people who have had a cryptogenic stroke. The committee noted that existing ongoing research may provide further data for these devices (see  section 3.51   and  section 4.19 ).

    yield of the BioMonitor 2‑AF and Confirm Rx (or later devices) for atrial fibrillation when used in people who have had a cryptogenic...

    Research recommendation
    Published
    26 October 2020

  3. The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters (MTG24)

    Evidence-based recommendations on The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters.

    Medical technologies guidance
    Last updated
    30 May 2019
    View recommendations

    Sections for MTG24

  4. Hypertension in adults: diagnosis and management (NG136)

    This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.

    NICE guideline
    Last updated
    21 November 2023
    View recommendations

    Sections for NG136

  5. microINR for anticoagulation therapy (MIB257)

    NICE has developed a medtech innovation briefing (MIB) on microINR for anticoagulation therapy .

    Medtech innovation briefing
    Published
    21 April 2021

  6. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of beta‑blockers for adults over 75 years with non‑rheumatic/calcific mitral stenosis, in both sinus rhythm and atrial fibrillation?

    non‑rheumatic/calcific mitral stenosis, in both sinus rhythm and atrial fibrillation? Any explanatory notes(if applicable) Source...

    Research recommendation
    Published
    16 December 2021

  7. Safe prescribing of high-risk drugs

    Atrial fibrillation: management (CG180)

    Shared learning
    Published
    10 October 2019

  8. Improving Medicines Optimisation for Care Home Residents and Providing Medicines Management Support to Care Homes - The Wigan Borough CCG Approach

    Wigan Borough CCG has employed a team of pharmacists and pharmacy technicians to work with GP practices, residential and nursing homes to carry out structured medication reviews for care homes

    Shared learning
    Last updated
    10 May 2021

  9. Improving patients time in range on warfarin

    Atrial fibrillation and heart valve disease: self-monitoring coagulation status using

    Shared learning
    Last updated
    10 May 2021

  10. Optimising Medication in patients with Chronic Heart Failure

    blood pressure management, lipid management and anticoagulation in atrial fibrillation. Reviewed whether the relevant patient monitoring...

    Shared learning
    Last updated
    12 November 2019

  11. Thoracoscopically assisted mitral valve surgery (IPG245)

    Evidence-based recommendations on thoracoscopically assisted mitral valve surgery. This involves repairing a defective valve through one or more small incisions between the ribs rather than one large incision through the breastbone (sternum).

    Interventional procedures guidance
    Published
    12 December 2007
    View recommendations

    Sections for IPG245

  12. The effect of COVID-19 related lockdown on patients taking warfarin

    approach is best suited to work when following NICE guidance for atrial fibrillation NG196 Guidance the shared learning

    Shared learning
    Last updated
    10 May 2021

  13. Irreversible electroporation for treating primary lung cancer and metastases in the lung (IPG441)

    Evidence-based recommendations on irreversible electroporation for treating primary lung cancer and metastases in the lung. This involves using electrical pulses to kill cancer cells.

    Interventional procedures guidance
    Published
    23 February 2013
    View recommendations

    Sections for IPG441

  14. Irreversible electroporation for treating renal cancer (IPG443)

    Evidence-based recommendations on irreversible electroporation (IRE) for treating renal cancer. This involves using electrical pulses to kill cancer cells, applied directly to the tumour through special needles.

    Interventional procedures guidance
    Published
    23 February 2013
    View recommendations

    Sections for IPG443

  15. CareLink network service for remote monitoring of people with cardiac devices (MIB64)

    NICE has developed a medtech innovation briefing (MIB) on the CareLink network service for remote monitoring of people with cardiac devices

    Medtech innovation briefing
    Published
    24 May 2016